Cargando…

Skeletal Fragility in Type 2 Diabetes Mellitus

Type 2 diabetes (T2D) is associated with an increased risk of fracture, which has been reported in several epidemiological studies. However, bone mineral density in T2D is increased and underestimates the fracture risk. Common risk factors for fracture do not fully explain the increased fracture ris...

Descripción completa

Detalles Bibliográficos
Autores principales:	Starup-Linde, Jakob, Hygum, Katrine, Langdahl, Bente Lomholt
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Endocrine Society 2018
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6145952/ https://www.ncbi.nlm.nih.gov/pubmed/30229573 http://dx.doi.org/10.3803/EnM.2018.33.3.339

Ejemplares similares

Type 1 Diabetes and Bone Fragility: Links and Risks
por: Starup-Linde, Jakob, et al.
Publicado: (2019)

Diabetes and bone
por: Hygum, Katrine, et al.
Publicado: (2019)

Bone Density and Structure in Overweight Men With and Without Diabetes
por: Starup-Linde, Jakob, et al.
Publicado: (2022)

Hypercalcemia in metastatic GIST caused by systemic elevated calcitriol: a case report and review of the literature
por: Hygum, Katrine, et al.
Publicado: (2015)

Associations of Circulating Osteoglycin With Bone Parameters and Metabolic Markers in Patients With Diabetes
por: Starup-Linde, Jakob Kau, et al.
Publicado: (2021)

Treatment of Osteoporosis: Unmet Needs and Emerging Solutions
por: Langdahl, Bente Lomholt, et al.
Publicado: (2018)

Predictors of Mortality Subsequent to a Fracture in Diabetes Mellitus Patients
por: Westberg-Rasmussen, Sidse, et al.
Publicado: (2015)

Diabetes, Biochemical Markers of Bone Turnover, Diabetes Control, and Bone
por: Starup-Linde, Jakob
Publicado: (2013)

Pathophysiology and Management of Type 2 Diabetes Mellitus Bone Fragility
por: Eller-Vainicher, C., et al.
Publicado: (2020)

The Effect of Effervescent and Buffered Alendronate Compared to Conventional Alendronate on Markers of Bone Turnover: A Randomized Non-inferiority Trial
por: Hikmet, Rawan, et al.
Publicado: (2023)

Alendronate Use and Risk of Type 2 Diabetes: A Nationwide Danish Nested Case-Control Study
por: Viggers, Rikke, et al.
Publicado: (2021)

The Efficacy of Alendronate Versus Denosumab on Major Osteoporotic Fracture Risk in Elderly Patients With Diabetes Mellitus: A Danish Retrospective Cohort Study
por: Viggers, Rikke, et al.
Publicado: (2022)

OR13-02 Treatment with Zoledronic Acid Subsequent to Denosumab Cannot Fully Prevent Bone Loss
por: Sølling, Anne Sophie K, et al.
Publicado: (2020)

Type 2 diabetes mellitus and bone fragility: Special focus on bone imaging
por: Choi, Yong Jun, et al.
Publicado: (2016)

Diabetes Mellitus-induced Bone Fragility
por: Kanazawa, Ippei, et al.
Publicado: (2018)

The Impact of Multifaceted Osteoporosis Group Education on Patients' Decision-Making regarding Treatment Options and Lifestyle Changes
por: Jensen, Annesofie L., et al.
Publicado: (2018)

Editorial: Diabetes and bone - from cell to human
por: Vestergaard, Peter, et al.
Publicado: (2022)

Associations with fracture in patients with diabetes: a nested case–control study
por: Starup-Linde, Jakob, et al.
Publicado: (2016)

Vascular deficits contributing to skeletal fragility in type 1 diabetes
por: Draghici, Adina E., et al.
Publicado: (2023)

Systematic Review: Are the Elderly With Diabetes Mellitus Type 2 Prone to Fragility Fractures?
por: Papaioannou, Ioannis, et al.
Publicado: (2021)

Preparing the Leaders of Tomorrow: Learnings from a Two-Year Community of Practice in Fragility Fractures
por: Murray, Suzanne, et al.
Publicado: (2022)

Type 2 diabetes and bone fragility in children and adults
por: Faienza, Maria Felicia, et al.
Publicado: (2022)

SAT232 Patients With Chronic Hypoparathyroidism Have Higher Risk Of Vertebral Fracture And Lower Risk Of Femoral Fracture Compared To Controls
por: Bjornsdottir, Sigridur, et al.
Publicado: (2023)

Skeletal stem cells and their contribution to skeletal fragility: senescence and rejuvenation
por: Aldahmash, Abdullah
Publicado: (2015)

Critical review of bone health, fracture risk and management of bone fragility in diabetes mellitus
por: Palui, Rajan, et al.
Publicado: (2021)

Osteoporosis and Fragility Fractures in Type 2 Diabetes
por: Chiodini, Iacopo, et al.
Publicado: (2020)

Diabetes and Bone Fragility
por: Romero-Díaz, Camila, et al.
Publicado: (2020)

The complex pathophysiology of bone fragility in obesity and type 2 diabetes mellitus: therapeutic targets to promote osteogenesis
por: Bathina, Siresha, et al.
Publicado: (2023)

Rethinking Fragility Fractures in Type 2 Diabetes: The Link between Hyperinsulinaemia and Osteofragilitas
por: Cooper, Isabella D., et al.
Publicado: (2021)

The impact of preadmission oral bisphosphonate use on 30-day mortality following stroke: a population-based cohort study of 100,043 patients
por: Christensen, Diana Hedevang, et al.
Publicado: (2015)

Bone fragility in patients affected by congenital diseases non skeletal in origin
por: Masi, L., et al.
Publicado: (2021)

Effect of obesity on fragility fractures, BMD and vitamin D levels in postmenopausal women. Influence of type 2 diabetes mellitus
por: de Tejada-Romero, M. J. Gómez, et al.
Publicado: (2022)

A mitochondrial proteome profile indicative of type 2 diabetes mellitus in skeletal muscles
por: Chae, Sehyun, et al.
Publicado: (2018)

Skeletal Senescence with Aging and Type 2 Diabetes
por: Farr, Joshua Nicholas
Publicado: (2023)

Smoking and Type 2 Diabetes Mellitus
por: Chang, Sang Ah
Publicado: (2012)

Pathophysiology of Type 2 Diabetes Mellitus
por: Galicia-Garcia, Unai, et al.
Publicado: (2020)

Raloxifene Prevents Skeletal Fragility in Adult Female Zucker Diabetic Sprague-Dawley Rats
por: Hill Gallant, Kathleen M., et al.
Publicado: (2014)

Prevention of type 2 diabetes mellitus in women with previous gestational diabetes mellitus
por: Moon, Joon Ho, et al.
Publicado: (2017)

Impaired Bone Matrix: The Key to Fragility in Type 2 Diabetes?
por: Hernandez, Christopher J, et al.
Publicado: (2021)

SGLT2 inhibitor treatment is not associated with an increased risk of osteoporotic fractures when compared to GLP-1 receptor agonists: A nationwide cohort study
por: Al-Mashhadi, Zheer Kejlberg, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jl3epudjs67slfd342turhhr40